Ming‐Feng Hou
Kaohsiung Medical University Chung-Ho Memorial Hospital(TW)Shanghai Pulmonary Hospital(CN)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Epigenetics and DNA Methylation, Cytokine Signaling Pathways and Interactions, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial(2012)2,016 cited
- → Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial(2020)594 cited
- → Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway(2018)537 cited
- → Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancers(2005)419 cited
- → New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis(2017)383 cited
- → Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties(2013)326 cited